STOCK OPTIONS |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK OPTIONS |
On February 4, 2022, the Company adjusted the exercise price of the options granted to Mr. Simpson from $ per share to $ per share.
On September 24, 2021, the Company extended the expiration date of the options granted to Mr. Simpson from April 6, 2022 to .
During the year ended December 31, 2021, Mr. Simpson exercised options to purchase shares of Restricted and Non-Trading shares at $ per share. The total exercise value was $ and this reduced the accrued salary payable to Mr. Simpson to $.
During the three months ended March 31, 2022 and 2021, compensation expense related to stock options was $. As of March 31, 2022, there was unrecognized compensation cost related to non-vested stock options.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||